ZA200401714B - - Google Patents

Info

Publication number

ZA200401714B

ZA200401714B ZA200401714A ZA200401714A ZA200401714B ZA 200401714 B ZA200401714 B ZA 200401714B ZA 200401714 A ZA200401714 A ZA 200401714A ZA 200401714 A ZA200401714 A ZA 200401714A ZA 200401714 B ZA200401714 B ZA 200401714B

Authority

ZA

South Africa

Prior art keywords

antigenic

proteins

cells

peptides

population

Prior art date

2001-08-20

Links

• Espacenet
• Global Dossier
• Discuss

• 108090000623 proteins and genes Proteins 0.000 claims description 341
• 230000000890 antigenic effect Effects 0.000 claims description 330
• 102000004169 proteins and genes Human genes 0.000 claims description 322
• 210000004027 cell Anatomy 0.000 claims description 307
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 207
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 185
• 102000002812 Heat-Shock Proteins Human genes 0.000 claims description 177
• 108010004889 Heat-Shock Proteins Proteins 0.000 claims description 177
• 238000000034 method Methods 0.000 claims description 172
• 238000002360 preparation method Methods 0.000 claims description 124
• 206010028980 Neoplasm Diseases 0.000 claims description 79
• 239000002245 particle Substances 0.000 claims description 58
• 201000011510 cancer Diseases 0.000 claims description 55
• 230000003612 virological effect Effects 0.000 claims description 53
• 230000001413 cellular effect Effects 0.000 claims description 49
• 102000035195 Peptidases Human genes 0.000 claims description 46
• 108091005804 Peptidases Proteins 0.000 claims description 46
• 239000012528 membrane Substances 0.000 claims description 38
• 239000004365 Protease Substances 0.000 claims description 36
• 239000000203 mixture Substances 0.000 claims description 36
• 239000000427 antigen Substances 0.000 claims description 33
• 108091007433 antigens Proteins 0.000 claims description 32
• 238000000338 in vitro Methods 0.000 claims description 32
• 102000036639 antigens Human genes 0.000 claims description 31
• 230000000536 complexating effect Effects 0.000 claims description 29
• 230000001086 cytosolic effect Effects 0.000 claims description 29
• 208000035473 Communicable disease Diseases 0.000 claims description 26
• 101710163595 Chaperone protein DnaK Proteins 0.000 claims description 25
• 101710178376 Heat shock 70 kDa protein Proteins 0.000 claims description 25
• 101710152018 Heat shock cognate 70 kDa protein Proteins 0.000 claims description 25
• 208000015181 infectious disease Diseases 0.000 claims description 24
• 230000028993 immune response Effects 0.000 claims description 20
• 230000029087 digestion Effects 0.000 claims description 19
• 239000012678 infectious agent Substances 0.000 claims description 18
• 235000019419 proteases Nutrition 0.000 claims description 18
• DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 17
• 125000000539 amino acid group Chemical group 0.000 claims description 13
• 238000003776 cleavage reaction Methods 0.000 claims description 12
• 230000002163 immunogen Effects 0.000 claims description 12
• 230000007017 scission Effects 0.000 claims description 12
• 230000002378 acidificating effect Effects 0.000 claims description 11
• 210000000172 cytosol Anatomy 0.000 claims description 11
• 239000003795 chemical substances by application Substances 0.000 claims description 10
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 9
• 108010015078 Pregnancy-Associated alpha 2-Macroglobulins Proteins 0.000 claims description 9
• 210000000612 antigen-presenting cell Anatomy 0.000 claims description 9
• 102100033312 Alpha-2-macroglobulin Human genes 0.000 claims description 8
• -1 gp96 Proteins 0.000 claims description 8
• 238000004519 manufacturing process Methods 0.000 claims description 8
• 235000019833 protease Nutrition 0.000 claims description 8
• 102000006010 Protein Disulfide-Isomerase Human genes 0.000 claims description 7
• 238000006911 enzymatic reaction Methods 0.000 claims description 7
• 108020003519 protein disulfide isomerase Proteins 0.000 claims description 7
• 108090000631 Trypsin Proteins 0.000 claims description 6
• 102000004142 Trypsin Human genes 0.000 claims description 6
• 230000001939 inductive effect Effects 0.000 claims description 6
• 108020004707 nucleic acids Proteins 0.000 claims description 6
• 102000039446 nucleic acids Human genes 0.000 claims description 6
• 150000007523 nucleic acids Chemical class 0.000 claims description 6
• 239000012588 trypsin Substances 0.000 claims description 6
• 108090000549 Calreticulin Proteins 0.000 claims description 5
• 239000003814 drug Substances 0.000 claims description 5
• 210000002472 endoplasmic reticulum Anatomy 0.000 claims description 5
• 210000003463 organelle Anatomy 0.000 claims description 5
• 108090000317 Chymotrypsin Proteins 0.000 claims description 4
• 101000738180 Euglena gracilis Chaperonin CPN60, mitochondrial Proteins 0.000 claims description 4
• 101150051208 HSPH1 gene Proteins 0.000 claims description 4
• 102100031624 Heat shock protein 105 kDa Human genes 0.000 claims description 4
• 102100032510 Heat shock protein HSP 90-beta Human genes 0.000 claims description 4
• 101001016856 Homo sapiens Heat shock protein HSP 90-beta Proteins 0.000 claims description 4
• 101000988090 Leishmania donovani Heat shock protein 83 Proteins 0.000 claims description 4
• 101100071630 Mesocentrotus franciscanus HSP110 gene Proteins 0.000 claims description 4
• 101100451677 Mus musculus Hspa4 gene Proteins 0.000 claims description 4
• 210000000170 cell membrane Anatomy 0.000 claims description 4
• 210000002421 cell wall Anatomy 0.000 claims description 4
• 229960002376 chymotrypsin Drugs 0.000 claims description 4
• 108010067372 Pancreatic elastase Proteins 0.000 claims description 3
• 102000016387 Pancreatic elastase Human genes 0.000 claims description 3
• 108090000526 Papain Proteins 0.000 claims description 3
• 102000057297 Pepsin A Human genes 0.000 claims description 3
• 108090000284 Pepsin A Proteins 0.000 claims description 3
• 108090001109 Thermolysin Proteins 0.000 claims description 3
• 239000002671 adjuvant Substances 0.000 claims description 3
• 108010008714 glucose-regulated protein 170 Proteins 0.000 claims description 3
• 235000019834 papain Nutrition 0.000 claims description 3
• 229940055729 papain Drugs 0.000 claims description 3
• 229940111202 pepsin Drugs 0.000 claims description 3
• LKDMKWNDBAVNQZ-UHFFFAOYSA-N 4-[[1-[[1-[2-[[1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)NC(C)C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(C(=O)NC=1C=CC(=CC=1)[N+]([O-])=O)CC1=CC=CC=C1 LKDMKWNDBAVNQZ-UHFFFAOYSA-N 0.000 claims description 2
• 108090000617 Cathepsin G Proteins 0.000 claims description 2
• 102000004173 Cathepsin G Human genes 0.000 claims description 2
• ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 claims description 2
• 210000005260 human cell Anatomy 0.000 claims description 2
• 230000002132 lysosomal effect Effects 0.000 claims description 2
• 230000002438 mitochondrial effect Effects 0.000 claims description 2
• 230000000717 retained effect Effects 0.000 claims 6
• 102000004082 Calreticulin Human genes 0.000 claims 2
• 108090000144 Human Proteins Proteins 0.000 claims 1
• 102000003839 Human Proteins Human genes 0.000 claims 1
• 239000003431 cross linking reagent Substances 0.000 claims 1
• 230000000415 inactivating effect Effects 0.000 claims 1
• 235000018102 proteins Nutrition 0.000 description 222
• 244000052769 pathogen Species 0.000 description 32
• 239000006228 supernatant Substances 0.000 description 29
• 230000001717 pathogenic effect Effects 0.000 description 26
• YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 26
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 24
• ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 23
• ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 22
• 108020004414 DNA Proteins 0.000 description 18
• 230000002265 prevention Effects 0.000 description 18
• 238000006243 chemical reaction Methods 0.000 description 17
• 238000000746 purification Methods 0.000 description 17
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 15
• 239000002953 phosphate buffered saline Substances 0.000 description 15
• 241000700605 Viruses Species 0.000 description 14
• 239000000872 buffer Substances 0.000 description 14
• 239000000463 material Substances 0.000 description 14
• 239000008188 pellet Substances 0.000 description 14
• 210000001519 tissue Anatomy 0.000 description 14
• 238000002955 isolation Methods 0.000 description 13
• 210000004881 tumor cell Anatomy 0.000 description 13
• 108010062580 Concanavalin A Proteins 0.000 description 12
• 239000012634 fragment Substances 0.000 description 12
• 239000011780 sodium chloride Substances 0.000 description 12
• 150000001413 amino acids Chemical group 0.000 description 11
• 239000011575 calcium Substances 0.000 description 11
• 239000011777 magnesium Substances 0.000 description 11
• UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 10
• BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 10
• 229910052921 ammonium sulfate Inorganic materials 0.000 description 10
• 235000011130 ammonium sulphate Nutrition 0.000 description 10
• 230000014509 gene expression Effects 0.000 description 10
• 239000012139 lysis buffer Substances 0.000 description 10
• 102000004190 Enzymes Human genes 0.000 description 9
• 108090000790 Enzymes Proteins 0.000 description 9
• 229940088598 enzyme Drugs 0.000 description 9
• 239000013604 expression vector Substances 0.000 description 9
• 238000003752 polymerase chain reaction Methods 0.000 description 9
• 229920002684 Sepharose Polymers 0.000 description 8
• 230000003834 intracellular effect Effects 0.000 description 8
• 239000002773 nucleotide Substances 0.000 description 8
• 125000003729 nucleotide group Chemical group 0.000 description 8
• 238000000527 sonication Methods 0.000 description 8
• 101710113864 Heat shock protein 90 Proteins 0.000 description 7
• 102100034051 Heat shock protein HSP 90-alpha Human genes 0.000 description 7
• 235000001014 amino acid Nutrition 0.000 description 7
• 238000005119 centrifugation Methods 0.000 description 7
• 239000006166 lysate Substances 0.000 description 7
• 239000000523 sample Substances 0.000 description 7
• 238000010008 shearing Methods 0.000 description 7
• 108091028043 Nucleic acid sequence Proteins 0.000 description 6
• 239000002299 complementary DNA Substances 0.000 description 6
• 230000008569 process Effects 0.000 description 6
• 230000002797 proteolythic effect Effects 0.000 description 6
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 6
• 239000012064 sodium phosphate buffer Substances 0.000 description 6
• 239000000243 solution Substances 0.000 description 6
• 102000006303 Chaperonin 60 Human genes 0.000 description 5
• 108010058432 Chaperonin 60 Proteins 0.000 description 5
• 241000233866 Fungi Species 0.000 description 5
• 102000043129 MHC class I family Human genes 0.000 description 5
• 108091054437 MHC class I family Proteins 0.000 description 5
• 241001465754 Metazoa Species 0.000 description 5
• 102000004245 Proteasome Endopeptidase Complex Human genes 0.000 description 5
• 108090000708 Proteasome Endopeptidase Complex Proteins 0.000 description 5
• 239000002253 acid Substances 0.000 description 5
• 230000000694 effects Effects 0.000 description 5
• 230000006862 enzymatic digestion Effects 0.000 description 5
• 230000000670 limiting effect Effects 0.000 description 5
• 210000004940 nucleus Anatomy 0.000 description 5
• 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 5
• 235000017557 sodium bicarbonate Nutrition 0.000 description 5
• 229910000030 sodium bicarbonate Inorganic materials 0.000 description 5
• 239000013598 vector Substances 0.000 description 5
• 241000894006 Bacteria Species 0.000 description 4
• 241000699670 Mus sp. Species 0.000 description 4
• 230000008901 benefit Effects 0.000 description 4
• 238000001574 biopsy Methods 0.000 description 4
• 210000004369 blood Anatomy 0.000 description 4
• 239000008280 blood Substances 0.000 description 4
• 201000010099 disease Diseases 0.000 description 4
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
• 238000001914 filtration Methods 0.000 description 4
• 210000000987 immune system Anatomy 0.000 description 4
• 238000001727 in vivo Methods 0.000 description 4
• 239000003112 inhibitor Substances 0.000 description 4
• 210000004962 mammalian cell Anatomy 0.000 description 4
• 238000002703 mutagenesis Methods 0.000 description 4
• 231100000350 mutagenesis Toxicity 0.000 description 4
• 244000045947 parasite Species 0.000 description 4
• 229920001184 polypeptide Polymers 0.000 description 4
• 108020003175 receptors Proteins 0.000 description 4
• 102000005962 receptors Human genes 0.000 description 4
• 238000003259 recombinant expression Methods 0.000 description 4
• 230000001105 regulatory effect Effects 0.000 description 4
• 238000010561 standard procedure Methods 0.000 description 4
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
• 229920000936 Agarose Polymers 0.000 description 3
• 102100029968 Calreticulin Human genes 0.000 description 3
• 108091026890 Coding region Proteins 0.000 description 3
• 241000701022 Cytomegalovirus Species 0.000 description 3
• 101100347633 Drosophila melanogaster Mhc gene Proteins 0.000 description 3
• 229910052791 calcium Inorganic materials 0.000 description 3
• 230000008859 change Effects 0.000 description 3
• 238000004587 chromatography analysis Methods 0.000 description 3
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 3
• 239000003599 detergent Substances 0.000 description 3
• 230000002255 enzymatic effect Effects 0.000 description 3
• 238000005194 fractionation Methods 0.000 description 3
• 230000006870 function Effects 0.000 description 3
• 238000004128 high performance liquid chromatography Methods 0.000 description 3
• 210000002865 immune cell Anatomy 0.000 description 3
• 230000036039 immunity Effects 0.000 description 3
• 238000000464 low-speed centrifugation Methods 0.000 description 3
• 229910052749 magnesium Inorganic materials 0.000 description 3
• 238000010369 molecular cloning Methods 0.000 description 3
• 239000013612 plasmid Substances 0.000 description 3
• 230000000069 prophylactic effect Effects 0.000 description 3
• 230000013777 protein digestion Effects 0.000 description 3
• 230000010076 replication Effects 0.000 description 3
• 230000004044 response Effects 0.000 description 3
• 108091008146 restriction endonucleases Proteins 0.000 description 3
• 230000035939 shock Effects 0.000 description 3
• 239000007858 starting material Substances 0.000 description 3
• 230000035882 stress Effects 0.000 description 3
• 230000001225 therapeutic effect Effects 0.000 description 3
• PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 3
• BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 2
• VGGGPCQERPFHOB-MCIONIFRSA-N Bestatin Chemical compound CC(C)C[C@H](C(O)=O)NC(=O)[C@@H](O)[C@H](N)CC1=CC=CC=C1 VGGGPCQERPFHOB-MCIONIFRSA-N 0.000 description 2
• VGGGPCQERPFHOB-UHFFFAOYSA-N Bestatin Natural products CC(C)CC(C(O)=O)NC(=O)C(O)C(N)CC1=CC=CC=C1 VGGGPCQERPFHOB-UHFFFAOYSA-N 0.000 description 2
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
• 108090000695 Cytokines Proteins 0.000 description 2
• 102000004127 Cytokines Human genes 0.000 description 2
• 229920002271 DEAE-Sepharose Polymers 0.000 description 2
• 230000004544 DNA amplification Effects 0.000 description 2
• 108050001049 Extracellular proteins Proteins 0.000 description 2
• 108010051815 Glutamyl endopeptidase Proteins 0.000 description 2
• 101150076784 HSP100 gene Proteins 0.000 description 2
• 101150031823 HSP70 gene Proteins 0.000 description 2
• 208000009889 Herpes Simplex Diseases 0.000 description 2
• 102000018713 Histocompatibility Antigens Class II Human genes 0.000 description 2
• 108091054438 MHC class II family Proteins 0.000 description 2
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
• 108090000157 Metallothionein Proteins 0.000 description 2
• BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
• 241001529936 Murinae Species 0.000 description 2
• 241000699666 Mus <mouse, genus> Species 0.000 description 2
• 108010021466 Mutant Proteins Proteins 0.000 description 2
• 102000008300 Mutant Proteins Human genes 0.000 description 2
• 108010033276 Peptide Fragments Proteins 0.000 description 2
• 102000007079 Peptide Fragments Human genes 0.000 description 2
• 241000606701 Rickettsia Species 0.000 description 2
• 206010039491 Sarcoma Diseases 0.000 description 2
• 229920005654 Sephadex Polymers 0.000 description 2
• 239000012507 Sephadex™ Substances 0.000 description 2
• 102000012479 Serine Proteases Human genes 0.000 description 2
• 108010022999 Serine Proteases Proteins 0.000 description 2
• 102000008063 Small Heat-Shock Proteins Human genes 0.000 description 2
• 230000005867 T cell response Effects 0.000 description 2
• 210000001744 T-lymphocyte Anatomy 0.000 description 2
• 108010067390 Viral Proteins Proteins 0.000 description 2
• 150000007513 acids Chemical class 0.000 description 2
• 230000002238 attenuated effect Effects 0.000 description 2
• 230000015572 biosynthetic process Effects 0.000 description 2
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
• 239000013592 cell lysate Substances 0.000 description 2
• 230000006037 cell lysis Effects 0.000 description 2
• 238000010367 cloning Methods 0.000 description 2
• 229960003964 deoxycholic acid Drugs 0.000 description 2
• 238000002523 gelfiltration Methods 0.000 description 2
• 238000009396 hybridization Methods 0.000 description 2
• 238000003119 immunoblot Methods 0.000 description 2
• 238000009169 immunotherapy Methods 0.000 description 2
• 239000002198 insoluble material Substances 0.000 description 2
• 230000002934 lysing effect Effects 0.000 description 2
• 230000014759 maintenance of location Effects 0.000 description 2
• 230000002503 metabolic effect Effects 0.000 description 2
• 238000002156 mixing Methods 0.000 description 2
• 230000035772 mutation Effects 0.000 description 2
• 230000009826 neoplastic cell growth Effects 0.000 description 2
• 230000001613 neoplastic effect Effects 0.000 description 2
• 235000015097 nutrients Nutrition 0.000 description 2
• 229910052760 oxygen Inorganic materials 0.000 description 2
• 239000001301 oxygen Substances 0.000 description 2
• 239000000137 peptide hydrolase inhibitor Substances 0.000 description 2
• 239000008363 phosphate buffer Substances 0.000 description 2
• 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 2
• 239000002244 precipitate Substances 0.000 description 2
• 239000002243 precursor Substances 0.000 description 2
• 230000031070 response to heat Effects 0.000 description 2
• 238000012552 review Methods 0.000 description 2
• 150000003839 salts Chemical class 0.000 description 2
• 238000000926 separation method Methods 0.000 description 2
• 210000002966 serum Anatomy 0.000 description 2
• 238000002741 site-directed mutagenesis Methods 0.000 description 2
• 108091052270 small heat shock protein (HSP20) family Proteins 0.000 description 2
• FHHPUSMSKHSNKW-SMOYURAASA-M sodium deoxycholate Chemical compound [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 FHHPUSMSKHSNKW-SMOYURAASA-M 0.000 description 2
• 239000007787 solid Substances 0.000 description 2
• 239000007790 solid phase Substances 0.000 description 2
• 239000000126 substance Substances 0.000 description 2
• 239000000725 suspension Substances 0.000 description 2
• 238000003786 synthesis reaction Methods 0.000 description 2
• 230000002194 synthesizing effect Effects 0.000 description 2
• 238000012360 testing method Methods 0.000 description 2
• 238000013518 transcription Methods 0.000 description 2
• 230000035897 transcription Effects 0.000 description 2
• 230000009466 transformation Effects 0.000 description 2
• 230000007704 transition Effects 0.000 description 2
• 238000013519 translation Methods 0.000 description 2
• 229950009811 ubenimex Drugs 0.000 description 2
• DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
• DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
• OUSKVHOYPHDTIA-DBRKOABJSA-N (3s,4s,5r,6r)-3,4,5,6,7-pentahydroxyheptan-2-one Chemical compound CC(=O)[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO OUSKVHOYPHDTIA-DBRKOABJSA-N 0.000 description 1
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
• WRDABNWSWOHGMS-UHFFFAOYSA-N AEBSF hydrochloride Chemical compound Cl.NCCC1=CC=C(S(F)(=O)=O)C=C1 WRDABNWSWOHGMS-UHFFFAOYSA-N 0.000 description 1
• 101150094949 APRT gene Proteins 0.000 description 1
• 102100029457 Adenine phosphoribosyltransferase Human genes 0.000 description 1
• 108010024223 Adenine phosphoribosyltransferase Proteins 0.000 description 1
• 108010087765 Antipain Proteins 0.000 description 1
• 108010083590 Apoproteins Proteins 0.000 description 1
• 102000006410 Apoproteins Human genes 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• OWNRRUFOJXFKCU-UHFFFAOYSA-N Bromadiolone Chemical compound C=1C=C(C=2C=CC(Br)=CC=2)C=CC=1C(O)CC(C=1C(OC2=CC=CC=C2C=1O)=O)C1=CC=CC=C1 OWNRRUFOJXFKCU-UHFFFAOYSA-N 0.000 description 1
• 241000282472 Canis lupus familiaris Species 0.000 description 1
• 102000014914 Carrier Proteins Human genes 0.000 description 1
• 102000005600 Cathepsins Human genes 0.000 description 1
• 108010084457 Cathepsins Proteins 0.000 description 1
• 241000606161 Chlamydia Species 0.000 description 1
• 101800004419 Cleaved form Proteins 0.000 description 1
• 241000709687 Coxsackievirus Species 0.000 description 1
• 102000015833 Cystatin Human genes 0.000 description 1
• 238000001712 DNA sequencing Methods 0.000 description 1
• 101100016370 Danio rerio hsp90a.1 gene Proteins 0.000 description 1
• 101100285708 Dictyostelium discoideum hspD gene Proteins 0.000 description 1
• 101100125027 Dictyostelium discoideum mhsp70 gene Proteins 0.000 description 1
• 108010016626 Dipeptides Proteins 0.000 description 1
• 206010058314 Dysplasia Diseases 0.000 description 1
• 238000002965 ELISA Methods 0.000 description 1
• 241001466953 Echovirus Species 0.000 description 1
• 241000709661 Enterovirus Species 0.000 description 1
• 241000991587 Enterovirus C Species 0.000 description 1
• YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
• 241000283086 Equidae Species 0.000 description 1
• 241000588724 Escherichia coli Species 0.000 description 1
• VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
• 239000005977 Ethylene Substances 0.000 description 1
• 241000206602 Eukaryota Species 0.000 description 1
• 241000282326 Felis catus Species 0.000 description 1
• 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 1
• 241000287828 Gallus gallus Species 0.000 description 1
• 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
• 102000003886 Glycoproteins Human genes 0.000 description 1
• 108090000288 Glycoproteins Proteins 0.000 description 1
• 208000031886 HIV Infections Diseases 0.000 description 1
• 108010045100 HSP27 Heat-Shock Proteins Proteins 0.000 description 1
• 102100039165 Heat shock protein beta-1 Human genes 0.000 description 1
• 241000700721 Hepatitis B virus Species 0.000 description 1
• 241000282412 Homo Species 0.000 description 1
• 101000899240 Homo sapiens Endoplasmic reticulum chaperone BiP Proteins 0.000 description 1
• 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 1
• 108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 description 1
• 102100029098 Hypoxanthine-guanine phosphoribosyltransferase Human genes 0.000 description 1
• 206010021143 Hypoxia Diseases 0.000 description 1
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
• 108010093096 Immobilized Enzymes Proteins 0.000 description 1
• 206010061598 Immunodeficiency Diseases 0.000 description 1
• 208000029462 Immunodeficiency disease Diseases 0.000 description 1
• 108700005091 Immunoglobulin Genes Proteins 0.000 description 1
• 108010002350 Interleukin-2 Proteins 0.000 description 1
• 108090000978 Interleukin-4 Proteins 0.000 description 1
• 108090001005 Interleukin-6 Proteins 0.000 description 1
• 108091092195 Intron Proteins 0.000 description 1
• 108010025815 Kanamycin Kinase Proteins 0.000 description 1
• FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
• 241000589248 Legionella Species 0.000 description 1
• 208000007764 Legionnaires' Disease Diseases 0.000 description 1
• 241000222722 Leishmania <genus> Species 0.000 description 1
• GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 description 1
• 239000000232 Lipid Bilayer Substances 0.000 description 1
• 108010010995 MART-1 Antigen Proteins 0.000 description 1
• 241000124008 Mammalia Species 0.000 description 1
• 241000712079 Measles morbillivirus Species 0.000 description 1
• 102100022430 Melanocyte protein PMEL Human genes 0.000 description 1
• 102100028389 Melanoma antigen recognized by T-cells 1 Human genes 0.000 description 1
• 102000003792 Metallothionein Human genes 0.000 description 1
• 206010054949 Metaplasia Diseases 0.000 description 1
• PPQNQXQZIWHJRB-UHFFFAOYSA-N Methylcholanthrene Chemical compound C1=CC=C2C3=CC4=CC=C(C)C(CC5)=C4C5=C3C=CC2=C1 PPQNQXQZIWHJRB-UHFFFAOYSA-N 0.000 description 1
• 241000713333 Mouse mammary tumor virus Species 0.000 description 1
• 102000015728 Mucins Human genes 0.000 description 1
• 108010063954 Mucins Proteins 0.000 description 1
• 102000007474 Multiprotein Complexes Human genes 0.000 description 1
• 108010085220 Multiprotein Complexes Proteins 0.000 description 1
• 241000711386 Mumps virus Species 0.000 description 1
• 101000899228 Mus musculus Endoplasmic reticulum chaperone BiP Proteins 0.000 description 1
• 241000204031 Mycoplasma Species 0.000 description 1
• KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
• 206010028813 Nausea Diseases 0.000 description 1
• 241000588653 Neisseria Species 0.000 description 1
• 102000007999 Nuclear Proteins Human genes 0.000 description 1
• 108010089610 Nuclear Proteins Proteins 0.000 description 1
• 241000150452 Orthohantavirus Species 0.000 description 1
• 241000283973 Oryctolagus cuniculus Species 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 241001631646 Papillomaviridae Species 0.000 description 1
• 241001494479 Pecora Species 0.000 description 1
• 108010076504 Protein Sorting Signals Proteins 0.000 description 1
• 102000016227 Protein disulphide isomerases Human genes 0.000 description 1
• 108050004742 Protein disulphide isomerases Proteins 0.000 description 1
• 241001068295 Replication defective viruses Species 0.000 description 1
• 241000725643 Respiratory syncytial virus Species 0.000 description 1
• 208000006257 Rinderpest Diseases 0.000 description 1
• 241000702670 Rotavirus Species 0.000 description 1
• 241000714474 Rous sarcoma virus Species 0.000 description 1
• 241000710799 Rubella virus Species 0.000 description 1
• 101100071627 Schizosaccharomyces pombe (strain 972 / ATCC 24843) swo1 gene Proteins 0.000 description 1
• 239000012506 Sephacryl® Substances 0.000 description 1
• 241000700584 Simplexvirus Species 0.000 description 1
• VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
• 241000282887 Suidae Species 0.000 description 1
• 101800001271 Surface protein Proteins 0.000 description 1
• 230000006052 T cell proliferation Effects 0.000 description 1
• 108010006785 Taq Polymerase Proteins 0.000 description 1
• 108010022394 Threonine synthase Proteins 0.000 description 1
• 102000006601 Thymidine Kinase Human genes 0.000 description 1
• 108020004440 Thymidine kinase Proteins 0.000 description 1
• 239000007983 Tris buffer Substances 0.000 description 1
• 241000223104 Trypanosoma Species 0.000 description 1
• 102000003425 Tyrosinase Human genes 0.000 description 1
• 108060008724 Tyrosinase Proteins 0.000 description 1
• 230000002159 abnormal effect Effects 0.000 description 1
• 238000002835 absorbance Methods 0.000 description 1
• 239000008351 acetate buffer Substances 0.000 description 1
• 230000009471 action Effects 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 238000001042 affinity chromatography Methods 0.000 description 1
• QFAADIRHLBXJJS-ZAZJUGBXSA-N amastatin Chemical compound CC(C)C[C@@H](N)[C@H](O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC(O)=O QFAADIRHLBXJJS-ZAZJUGBXSA-N 0.000 description 1
• 108010052590 amastatin Proteins 0.000 description 1
• 229940126575 aminoglycoside Drugs 0.000 description 1
• 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
• 230000003321 amplification Effects 0.000 description 1
• 230000000340 anti-metabolite Effects 0.000 description 1
• 230000005875 antibody response Effects 0.000 description 1
• 229940100197 antimetabolite Drugs 0.000 description 1
• 239000002256 antimetabolite Substances 0.000 description 1
• SDNYTAYICBFYFH-TUFLPTIASA-N antipain Chemical compound NC(N)=NCCC[C@@H](C=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 SDNYTAYICBFYFH-TUFLPTIASA-N 0.000 description 1
• 238000013459 approach Methods 0.000 description 1
• 235000009697 arginine Nutrition 0.000 description 1
• 125000000637 arginyl group Chemical class N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
• CKLJMWTZIZZHCS-REOHCLBHSA-N aspartic acid group Chemical group N[C@@H](CC(=O)O)C(=O)O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
• 244000052616 bacterial pathogen Species 0.000 description 1
• 239000011324 bead Substances 0.000 description 1
• 108091008324 binding proteins Proteins 0.000 description 1
• 230000003851 biochemical process Effects 0.000 description 1
• 230000005540 biological transmission Effects 0.000 description 1
• 210000001124 body fluid Anatomy 0.000 description 1
• 239000010839 body fluid Substances 0.000 description 1
• 239000007975 buffered saline Substances 0.000 description 1
• 239000003183 carcinogenic agent Substances 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 238000004113 cell culture Methods 0.000 description 1
• 230000010261 cell growth Effects 0.000 description 1
• 238000001516 cell proliferation assay Methods 0.000 description 1
• 230000011722 cellular response to heat Effects 0.000 description 1
• 210000002230 centromere Anatomy 0.000 description 1
• 230000001876 chaperonelike Effects 0.000 description 1
• 238000012512 characterization method Methods 0.000 description 1
• 235000013330 chicken meat Nutrition 0.000 description 1
• 210000000349 chromosome Anatomy 0.000 description 1
• 230000037012 chymotrypsin-like activity Effects 0.000 description 1
• 238000004440 column chromatography Methods 0.000 description 1
• 230000000295 complement effect Effects 0.000 description 1
• 238000004590 computer program Methods 0.000 description 1
• 108050004038 cystatin Proteins 0.000 description 1
• 210000000805 cytoplasm Anatomy 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• 238000012217 deletion Methods 0.000 description 1
• 230000037430 deletion Effects 0.000 description 1
• 238000001514 detection method Methods 0.000 description 1
• 238000000502 dialysis Methods 0.000 description 1
• 239000005546 dideoxynucleotide Substances 0.000 description 1
• 102000004419 dihydrofolate reductase Human genes 0.000 description 1
• 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
• 101150052825 dnaK gene Proteins 0.000 description 1
• 229940079593 drug Drugs 0.000 description 1
• 238000001035 drying Methods 0.000 description 1
• 239000003480 eluent Substances 0.000 description 1
• 238000010828 elution Methods 0.000 description 1
• 238000001839 endoscopy Methods 0.000 description 1
• 239000003623 enhancer Substances 0.000 description 1
• 238000001952 enzyme assay Methods 0.000 description 1
• 238000001976 enzyme digestion Methods 0.000 description 1
• 210000003527 eukaryotic cell Anatomy 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 238000000855 fermentation Methods 0.000 description 1
• 230000004151 fermentation Effects 0.000 description 1
• 210000002950 fibroblast Anatomy 0.000 description 1
• 239000012530 fluid Substances 0.000 description 1
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
• 238000007710 freezing Methods 0.000 description 1
• 230000008014 freezing Effects 0.000 description 1
• 230000004927 fusion Effects 0.000 description 1
• 239000003862 glucocorticoid Substances 0.000 description 1
• 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
• 230000012010 growth Effects 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 208000005252 hepatitis A Diseases 0.000 description 1
• 208000002672 hepatitis B Diseases 0.000 description 1
• 208000010710 hepatitis C virus infection Diseases 0.000 description 1
• 238000000703 high-speed centrifugation Methods 0.000 description 1
• 210000004408 hybridoma Anatomy 0.000 description 1
• 230000002209 hydrophobic effect Effects 0.000 description 1
• 108010002685 hygromycin-B kinase Proteins 0.000 description 1
• 206010020718 hyperplasia Diseases 0.000 description 1
• 230000007954 hypoxia Effects 0.000 description 1
• 239000005457 ice water Substances 0.000 description 1
• 230000003100 immobilizing effect Effects 0.000 description 1
• 230000001900 immune effect Effects 0.000 description 1
• 239000012642 immune effector Substances 0.000 description 1
• 230000037189 immune system physiology Effects 0.000 description 1
• 230000003053 immunization Effects 0.000 description 1
• 238000002649 immunization Methods 0.000 description 1
• 230000007813 immunodeficiency Effects 0.000 description 1
• 230000002998 immunogenetic effect Effects 0.000 description 1
• 230000005847 immunogenicity Effects 0.000 description 1
• 230000016784 immunoglobulin production Effects 0.000 description 1
• 239000000367 immunologic factor Substances 0.000 description 1
• 229940121354 immunomodulator Drugs 0.000 description 1
• 230000001976 improved effect Effects 0.000 description 1
• 230000006872 improvement Effects 0.000 description 1
• 238000011534 incubation Methods 0.000 description 1
• 230000002458 infectious effect Effects 0.000 description 1
• 230000002757 inflammatory effect Effects 0.000 description 1
• 206010022000 influenza Diseases 0.000 description 1
• 230000002401 inhibitory effect Effects 0.000 description 1
• 238000003780 insertion Methods 0.000 description 1
• 230000037431 insertion Effects 0.000 description 1
• 230000010354 integration Effects 0.000 description 1
• 230000003993 interaction Effects 0.000 description 1
• 229940079322 interferon Drugs 0.000 description 1
• 108090000237 interleukin-24 Proteins 0.000 description 1
• 102000003898 interleukin-24 Human genes 0.000 description 1
• GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 description 1
• 108010052968 leupeptin Proteins 0.000 description 1
• 210000002751 lymph Anatomy 0.000 description 1
• 235000018977 lysine Nutrition 0.000 description 1
• 125000003588 lysine group Chemical class [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
• 210000002540 macrophage Anatomy 0.000 description 1
• 238000012423 maintenance Methods 0.000 description 1
• 239000003550 marker Substances 0.000 description 1
• 238000004949 mass spectrometry Methods 0.000 description 1
• 230000007246 mechanism Effects 0.000 description 1
• 230000001404 mediated effect Effects 0.000 description 1
• 108020004999 messenger RNA Proteins 0.000 description 1
• 230000015689 metaplastic ossification Effects 0.000 description 1
• 230000001394 metastastic effect Effects 0.000 description 1
• 206010061289 metastatic neoplasm Diseases 0.000 description 1
• MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
• 229960000485 methotrexate Drugs 0.000 description 1
• HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 description 1
• 244000005700 microbiome Species 0.000 description 1
• 210000003470 mitochondria Anatomy 0.000 description 1
• 238000012986 modification Methods 0.000 description 1
• 230000004048 modification Effects 0.000 description 1
• 238000001823 molecular biology technique Methods 0.000 description 1
• 229940051875 mucins Drugs 0.000 description 1
• HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 description 1
• 229960000951 mycophenolic acid Drugs 0.000 description 1
• 238000003199 nucleic acid amplification method Methods 0.000 description 1
• 238000007899 nucleic acid hybridization Methods 0.000 description 1
• 230000000269 nucleophilic effect Effects 0.000 description 1
• 230000007170 pathology Effects 0.000 description 1
• FAXGPCHRFPCXOO-LXTPJMTPSA-N pepstatin A Chemical compound OC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C FAXGPCHRFPCXOO-LXTPJMTPSA-N 0.000 description 1
• 108010004108 peptidylglutamylpeptide hydrolase Proteins 0.000 description 1
• 239000008194 pharmaceutical composition Substances 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• 230000009894 physiological stress Effects 0.000 description 1
• 230000001855 preneoplastic effect Effects 0.000 description 1
• 239000000047 product Substances 0.000 description 1
• 230000001902 propagating effect Effects 0.000 description 1
• 239000012460 protein solution Substances 0.000 description 1
• RYVMUASDIZQXAA-UHFFFAOYSA-N pyranoside Natural products O1C2(OCC(C)C(OC3C(C(O)C(O)C(CO)O3)O)C2)C(C)C(C2(CCC3C4(C)CC5O)C)C1CC2C3CC=C4CC5OC(C(C1O)O)OC(CO)C1OC(C1OC2C(C(OC3C(C(O)C(O)C(CO)O3)O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OCC(O)C(O)C1O RYVMUASDIZQXAA-UHFFFAOYSA-N 0.000 description 1
• 239000002516 radical scavenger Substances 0.000 description 1
• 230000008707 rearrangement Effects 0.000 description 1
• 230000003362 replicative effect Effects 0.000 description 1
• 239000011347 resin Substances 0.000 description 1
• 229920005989 resin Polymers 0.000 description 1
• 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
• 238000012216 screening Methods 0.000 description 1
• 230000003248 secreting effect Effects 0.000 description 1
• 230000028327 secretion Effects 0.000 description 1
• 230000001235 sensitizing effect Effects 0.000 description 1
• 239000013605 shuttle vector Substances 0.000 description 1
• 239000002002 slurry Substances 0.000 description 1
• 239000011734 sodium Substances 0.000 description 1
• 229910052708 sodium Inorganic materials 0.000 description 1
• 239000001632 sodium acetate Substances 0.000 description 1
• 235000017281 sodium acetate Nutrition 0.000 description 1
• 239000007974 sodium acetate buffer Substances 0.000 description 1
• 239000001488 sodium phosphate Substances 0.000 description 1
• 229910000162 sodium phosphate Inorganic materials 0.000 description 1
• 210000004989 spleen cell Anatomy 0.000 description 1
• 230000010473 stable expression Effects 0.000 description 1
• 238000003756 stirring Methods 0.000 description 1
• 238000006467 substitution reaction Methods 0.000 description 1
• 239000000758 substrate Substances 0.000 description 1
• 238000001356 surgical procedure Methods 0.000 description 1
• 108091035539 telomere Proteins 0.000 description 1
• 238000010257 thawing Methods 0.000 description 1
• 238000011285 therapeutic regimen Methods 0.000 description 1
• 150000007970 thio esters Chemical class 0.000 description 1
• 238000001890 transfection Methods 0.000 description 1
• 238000012546 transfer Methods 0.000 description 1
• 238000009966 trimming Methods 0.000 description 1
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
• RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
• 230000001810 trypsinlike Effects 0.000 description 1
• 241000701161 unidentified adenovirus Species 0.000 description 1
• 241000712461 unidentified influenza virus Species 0.000 description 1
• 241001515965 unidentified phage Species 0.000 description 1
• 230000003442 weekly effect Effects 0.000 description 1